GEHC – GE HealthCare Technologies Inc
GEHC — Price & Forward EBITDA
Forward EBITDA (M)
Float Short %
2.4
Margin Of Safety %
31
Put/Call OI Ratio
0.65
EPS Next Q Diff
-0.27
EPS Last/This Y
0.5
EPS This/Next Y
0.51
Price
70.79
Target Price
93
Analyst Recom
1.83
Performance Q
-16.22
Upside
41.4%
Beta
1.31
Ticker: GEHC
of 1
| Date | Symbol | Latest | P/C OI | P/C Vol | Total OI |
|---|---|---|---|---|---|
| 2026-03-09 | GEHC | 75.62 | 0.66 | 1.94 | 45268 |
| 2026-03-10 | GEHC | 72.73 | 0.67 | 0.80 | 46274 |
| 2026-03-11 | GEHC | 72.64 | 0.67 | 0.73 | 46428 |
| 2026-03-12 | GEHC | 70.36 | 0.65 | 4.21 | 46265 |
| 2026-03-13 | GEHC | 70.33 | 0.65 | 4.19 | 46265 |
| Date | Symbol | Latest | P/C OI | P/C Vol | Total OI |
Current Page1 of 1
of 1
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
|---|---|---|---|---|---|
| 2026-03-09 | GEHC | 75.63 | 5.0 | 171.4 | 5.06 |
| 2026-03-10 | GEHC | 72.74 | 5.0 | 11.1 | 5.06 |
| 2026-03-11 | GEHC | 72.62 | 5.0 | 115.4 | 5.06 |
| 2026-03-12 | GEHC | 70.33 | 3.8 | 29.6 | 5.06 |
| 2026-03-13 | GEHC | 70.79 | 3.8 | 138.0 | 5.06 |
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
Current Page1 of 1
of 1
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
|---|---|---|---|---|
| 2026-03-06 | GEHC | 0.00 | 4.91 | 2.20 |
| 2026-03-09 | GEHC | 0.00 | 4.87 | 2.20 |
| 2026-03-10 | GEHC | 0.00 | 4.87 | 2.20 |
| 2026-03-11 | GEHC | 0.00 | 4.87 | 2.40 |
| 2026-03-12 | GEHC | 0.00 | 4.87 | 2.40 |
| 2026-03-13 | GEHC | 0.00 | 4.87 | 2.40 |
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
Current Page1 of 1
Last Quarter Act. EPS
1.44
Avg. EPS Est. Current Quarter
1.05
Avg. EPS Est. Next Quarter
1.17
Insider Transactions
Institutional Transactions
4.87
Beta
1.31
Average Sales Estimate Current Quarter
5026
Average Sales Estimate Next Quarter
5254
Fair Value
92.59
Quality Score
83
Growth Score
83
Sentiment Score
43
Actual DrawDown %
25.3
Max Drawdown 5-Year %
Target Price
93
P/E
15.54
Forward P/E
12.64
PEG
1.19
P/S
1.56
P/B
3.11
P/Free Cash Flow
21.43
EPS
4.55
Average EPS Est. Cur. Y
5.06
EPS Next Y. (Est.)
5.57
Target Price Estimates Raised
Target Price Estimates Lowered
Profit Margin
10.11
Relative Volume
1.35
Return on Equity vs Sector %
-7.7
Return on Equity vs Industry %
8.3
EPS 1 7Days Diff
EPS 1 30Days Diff
0.03
EBIT Estimation
138
GE HealthCare Technologies Inc.Sector: Healthcare
Industry: Medical Devices
Employees: 54000
GE HealthCare Technologies Inc. engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Advanced Visualization Solutions (AVS), Patient Care Solutions (PCS), and Pharmaceutical Diagnostics (PDx). The Imaging segment offers molecular imaging, computed tomography (CT) scanning, magnetic resonance (MR) imaging, X-ray systems, and women's health products. The AVS segment provides ultrasound, image guided therapies, and interventional solutions for screening, diagnosis, treatment, and monitoring of certain diseases in clinical areas, such as women's health, cardiovascular, and comprehensive care ultrasound as well as surgical visualization and guidance products. The PCS segment provides medical devices, consumables, services, and digital solutions. Its portfolio includes patient monitoring, diagnostic cardiology, consumables and services, digital solutions, maternal infant care, and anesthesia products. The PDx segment supplies diagnostic agents, including CT, angiography and X-ray, MR, single-photon emission computed tomography, and positron emission tomography to the radiology and nuclear medicine industries. The segment also provides contrast media pharmaceuticals that are administered to a patient prior to certain diagnostic scans to increase the visibility of tissues or structures during imaging exams; and molecular imaging agents or radiopharmaceuticals, which are molecular tracers labeled with radioisotopes. GE HealthCare Technologies Inc. was formerly known as GE Healthcare Holding LLC and changed its name to GE HealthCare Technologies Inc. in December 2022. The company was incorporated in 2022 and is headquartered in Chicago, Illinois.
GEHC
Latest News
—
Caricamento notizie per GEHC…
stock quote shares GEHC – GE HealthCare Technologies Inc Stock Price stock today
news today GEHC – GE HealthCare Technologies Inc stock forecast ,stock prediction 2023 2024 2025
marketwatch GEHC – GE HealthCare Technologies Inc yahoo finance google finance
stock history GEHC – GE HealthCare Technologies Inc invest stock market
stock prices GEHC premarket after hours
ticker GEHC fair value insiders trading